Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...

Pancreatic cancer (PC) is an aggressive malignancy marked by highinvasiveness, metastasis, and resistance to chemotherapy, presenting a significant global healthchallenge. Visceral obesity has been ...

Biocartis announced the launch of its real-time quantitative polymerase chain reaction assay to detect POLE and POLD1 mutations in endometrial cancer. Biocartis has launched a fully automated, ...

All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury Rapid access to CN Bio’s FDA-recognized human DILI assay to optimize and de-risk drug candidate selection 24 ...

Zhao et al. report valuable adverse effects on cell proliferation, differentiation and gene expression, possibly linked to reduced binding activity of the transcription factor GTF2IRD1 to the ...

Methods: We used male and female EC-specific tamoxifen-inducible OCT4 knockout and EC-lineage tracing (EC-OCT4 KO) mice to study the role of OCT4 in non-atherosclerotic conditions leading to ...

Adeno-associated virus (AAV) vectors play a pivotal role in gene therapy, delivering therapeutic genes with high precision and safety. However, a significant challenge in the biomanufacturing of these ...